nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextroamphetamine—CYP2D6—Gefitinib—lung cancer	0.0386	0.32	CbGbCtD
Dextroamphetamine—CYP2D6—Vinorelbine—lung cancer	0.0297	0.246	CbGbCtD
Dextroamphetamine—CYP2D6—Erlotinib—lung cancer	0.0228	0.189	CbGbCtD
Dextroamphetamine—CYP2D6—Vinblastine—lung cancer	0.0183	0.152	CbGbCtD
Dextroamphetamine—CYP2D6—Doxorubicin—lung cancer	0.0113	0.0932	CbGbCtD
Dextroamphetamine—Pseudoephedrine—IL2—lung cancer	0.00354	0.27	CrCbGaD
Dextroamphetamine—Tranylcypromine—CYP2A6—lung cancer	0.00163	0.124	CrCbGaD
Dextroamphetamine—Selegiline—CYP2A6—lung cancer	0.00127	0.0965	CrCbGaD
Dextroamphetamine—Tranylcypromine—CYP2E1—lung cancer	0.00116	0.0884	CrCbGaD
Dextroamphetamine—Amphetamine—CYP2A6—lung cancer	0.00105	0.0802	CrCbGaD
Dextroamphetamine—Benzyl alcohol—CYP2E1—lung cancer	0.000938	0.0714	CrCbGaD
Dextroamphetamine—Anorexia—Irinotecan—lung cancer	0.000925	0.00159	CcSEcCtD
Dextroamphetamine—Benzyl alcohol—CYP1A1—lung cancer	0.000925	0.0705	CrCbGaD
Dextroamphetamine—Anxiety—Cisplatin—lung cancer	0.000916	0.00157	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Gemcitabine—lung cancer	0.000914	0.00157	CcSEcCtD
Dextroamphetamine—Dizziness—Topotecan—lung cancer	0.00091	0.00156	CcSEcCtD
Dextroamphetamine—Tremor—Paclitaxel—lung cancer	0.000909	0.00156	CcSEcCtD
Dextroamphetamine—Anorexia—Gemcitabine—lung cancer	0.000901	0.00154	CcSEcCtD
Dextroamphetamine—Vomiting—Vinblastine—lung cancer	0.0009	0.00154	CcSEcCtD
Dextroamphetamine—Dizziness—Erlotinib—lung cancer	0.0009	0.00154	CcSEcCtD
Dextroamphetamine—Selegiline—CYP2E1—lung cancer	0.0009	0.0685	CrCbGaD
Dextroamphetamine—Erythema multiforme—Docetaxel—lung cancer	0.000893	0.00153	CcSEcCtD
Dextroamphetamine—Agitation—Paclitaxel—lung cancer	0.000891	0.00153	CcSEcCtD
Dextroamphetamine—Headache—Vinblastine—lung cancer	0.000887	0.00152	CcSEcCtD
Dextroamphetamine—Angioedema—Paclitaxel—lung cancer	0.000886	0.00152	CcSEcCtD
Dextroamphetamine—Toxic epidermal necrolysis—Methotrexate—lung cancer	0.000886	0.00152	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Cisplatin—lung cancer	0.000881	0.00151	CcSEcCtD
Dextroamphetamine—Insomnia—Irinotecan—lung cancer	0.000878	0.0015	CcSEcCtD
Dextroamphetamine—Infection—Cisplatin—lung cancer	0.000875	0.0015	CcSEcCtD
Dextroamphetamine—Vomiting—Topotecan—lung cancer	0.000875	0.0015	CcSEcCtD
Dextroamphetamine—Cerebrovascular accident—Doxorubicin—lung cancer	0.000869	0.00149	CcSEcCtD
Dextroamphetamine—Rash—Topotecan—lung cancer	0.000867	0.00149	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Vinorelbine—lung cancer	0.000867	0.00149	CcSEcCtD
Dextroamphetamine—Dermatitis—Topotecan—lung cancer	0.000867	0.00149	CcSEcCtD
Dextroamphetamine—Vomiting—Erlotinib—lung cancer	0.000865	0.00148	CcSEcCtD
Dextroamphetamine—Dyspnoea—Irinotecan—lung cancer	0.000865	0.00148	CcSEcCtD
Dextroamphetamine—Somnolence—Irinotecan—lung cancer	0.000863	0.00148	CcSEcCtD
Dextroamphetamine—Headache—Topotecan—lung cancer	0.000862	0.00148	CcSEcCtD
Dextroamphetamine—Tachycardia—Cisplatin—lung cancer	0.00086	0.00147	CcSEcCtD
Dextroamphetamine—Rash—Erlotinib—lung cancer	0.000858	0.00147	CcSEcCtD
Dextroamphetamine—Dermatitis—Erlotinib—lung cancer	0.000857	0.00147	CcSEcCtD
Dextroamphetamine—Palpitations—Paclitaxel—lung cancer	0.000857	0.00147	CcSEcCtD
Dextroamphetamine—Convulsion—Etoposide—lung cancer	0.000857	0.00147	CcSEcCtD
Dextroamphetamine—Insomnia—Gemcitabine—lung cancer	0.000855	0.00147	CcSEcCtD
Dextroamphetamine—Dyspepsia—Irinotecan—lung cancer	0.000854	0.00146	CcSEcCtD
Dextroamphetamine—Hypertension—Etoposide—lung cancer	0.000854	0.00146	CcSEcCtD
Dextroamphetamine—Headache—Erlotinib—lung cancer	0.000853	0.00146	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Cisplatin—lung cancer	0.000852	0.00146	CcSEcCtD
Dextroamphetamine—Asthenia—Vinorelbine—lung cancer	0.000844	0.00145	CcSEcCtD
Dextroamphetamine—Decreased appetite—Irinotecan—lung cancer	0.000844	0.00145	CcSEcCtD
Dextroamphetamine—Dyspnoea—Gemcitabine—lung cancer	0.000843	0.00144	CcSEcCtD
Dextroamphetamine—Chest pain—Etoposide—lung cancer	0.000842	0.00144	CcSEcCtD
Dextroamphetamine—Nausea—Vinblastine—lung cancer	0.000841	0.00144	CcSEcCtD
Dextroamphetamine—Somnolence—Gemcitabine—lung cancer	0.000841	0.00144	CcSEcCtD
Dextroamphetamine—Convulsion—Paclitaxel—lung cancer	0.00084	0.00144	CcSEcCtD
Dextroamphetamine—Anorexia—Cisplatin—lung cancer	0.00084	0.00144	CcSEcCtD
Dextroamphetamine—Affect lability—Doxorubicin—lung cancer	0.000839	0.00144	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Irinotecan—lung cancer	0.000838	0.00144	CcSEcCtD
Dextroamphetamine—Hypertension—Paclitaxel—lung cancer	0.000837	0.00144	CcSEcCtD
Dextroamphetamine—Fatigue—Irinotecan—lung cancer	0.000837	0.00143	CcSEcCtD
Dextroamphetamine—Constipation—Irinotecan—lung cancer	0.00083	0.00142	CcSEcCtD
Dextroamphetamine—Chest pain—Paclitaxel—lung cancer	0.000826	0.00142	CcSEcCtD
Dextroamphetamine—Anxiety—Paclitaxel—lung cancer	0.000823	0.00141	CcSEcCtD
Dextroamphetamine—Decreased appetite—Gemcitabine—lung cancer	0.000822	0.00141	CcSEcCtD
Dextroamphetamine—Nausea—Topotecan—lung cancer	0.000817	0.0014	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000816	0.0014	CcSEcCtD
Dextroamphetamine—Fatigue—Gemcitabine—lung cancer	0.000815	0.0014	CcSEcCtD
Dextroamphetamine—Constipation—Gemcitabine—lung cancer	0.000809	0.00139	CcSEcCtD
Dextroamphetamine—Nausea—Erlotinib—lung cancer	0.000808	0.00139	CcSEcCtD
Dextroamphetamine—Dry mouth—Paclitaxel—lung cancer	0.000808	0.00138	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Etoposide—lung cancer	0.000807	0.00138	CcSEcCtD
Dextroamphetamine—Mood swings—Doxorubicin—lung cancer	0.000807	0.00138	CcSEcCtD
Dextroamphetamine—Diarrhoea—Vinorelbine—lung cancer	0.000805	0.00138	CcSEcCtD
Dextroamphetamine—Infection—Etoposide—lung cancer	0.000802	0.00137	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Irinotecan—lung cancer	0.000794	0.00136	CcSEcCtD
Dextroamphetamine—Phenelzine—CYP2E1—lung cancer	0.000793	0.0604	CrCbGaD
Dextroamphetamine—Anaphylactic shock—Paclitaxel—lung cancer	0.000792	0.00136	CcSEcCtD
Dextroamphetamine—Tachycardia—Etoposide—lung cancer	0.000788	0.00135	CcSEcCtD
Dextroamphetamine—Infection—Paclitaxel—lung cancer	0.000786	0.00135	CcSEcCtD
Dextroamphetamine—Dyspnoea—Cisplatin—lung cancer	0.000786	0.00135	CcSEcCtD
Dextroamphetamine—Erectile dysfunction—Methotrexate—lung cancer	0.000783	0.00134	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Etoposide—lung cancer	0.00078	0.00134	CcSEcCtD
Dextroamphetamine—Dizziness—Vinorelbine—lung cancer	0.000778	0.00133	CcSEcCtD
Dextroamphetamine—Abdominal pain upper—Doxorubicin—lung cancer	0.000778	0.00133	CcSEcCtD
Dextroamphetamine—Photosensitivity reaction—Methotrexate—lung cancer	0.000776	0.00133	CcSEcCtD
Dextroamphetamine—Tachycardia—Paclitaxel—lung cancer	0.000773	0.00132	CcSEcCtD
Dextroamphetamine—Anorexia—Etoposide—lung cancer	0.00077	0.00132	CcSEcCtD
Dextroamphetamine—Abdominal pain—Irinotecan—lung cancer	0.000767	0.00131	CcSEcCtD
Dextroamphetamine—Body temperature increased—Irinotecan—lung cancer	0.000767	0.00131	CcSEcCtD
Dextroamphetamine—Toxic epidermal necrolysis—Doxorubicin—lung cancer	0.000767	0.00131	CcSEcCtD
Dextroamphetamine—Decreased appetite—Cisplatin—lung cancer	0.000766	0.00131	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Paclitaxel—lung cancer	0.000765	0.00131	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Cisplatin—lung cancer	0.000761	0.0013	CcSEcCtD
Dextroamphetamine—Depression—Methotrexate—lung cancer	0.000756	0.0013	CcSEcCtD
Dextroamphetamine—Anorexia—Paclitaxel—lung cancer	0.000755	0.00129	CcSEcCtD
Dextroamphetamine—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000752	0.00129	CcSEcCtD
Dextroamphetamine—Vomiting—Vinorelbine—lung cancer	0.000748	0.00128	CcSEcCtD
Dextroamphetamine—Body temperature increased—Gemcitabine—lung cancer	0.000747	0.00128	CcSEcCtD
Dextroamphetamine—Rash—Vinorelbine—lung cancer	0.000742	0.00127	CcSEcCtD
Dextroamphetamine—Dermatitis—Vinorelbine—lung cancer	0.000741	0.00127	CcSEcCtD
Dextroamphetamine—Headache—Vinorelbine—lung cancer	0.000737	0.00126	CcSEcCtD
Dextroamphetamine—Sweating—Methotrexate—lung cancer	0.000727	0.00125	CcSEcCtD
Dextroamphetamine—Palpitations—Docetaxel—lung cancer	0.000726	0.00125	CcSEcCtD
Dextroamphetamine—Dyspnoea—Etoposide—lung cancer	0.00072	0.00123	CcSEcCtD
Dextroamphetamine—Somnolence—Etoposide—lung cancer	0.000718	0.00123	CcSEcCtD
Dextroamphetamine—Insomnia—Paclitaxel—lung cancer	0.000716	0.00123	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Irinotecan—lung cancer	0.000715	0.00123	CcSEcCtD
Dextroamphetamine—Convulsion—Docetaxel—lung cancer	0.000712	0.00122	CcSEcCtD
Dextroamphetamine—Hypertension—Docetaxel—lung cancer	0.00071	0.00122	CcSEcCtD
Dextroamphetamine—Dyspnoea—Paclitaxel—lung cancer	0.000706	0.00121	CcSEcCtD
Dextroamphetamine—Somnolence—Paclitaxel—lung cancer	0.000704	0.00121	CcSEcCtD
Dextroamphetamine—Decreased appetite—Etoposide—lung cancer	0.000702	0.0012	CcSEcCtD
Dextroamphetamine—Chest pain—Docetaxel—lung cancer	0.0007	0.0012	CcSEcCtD
Dextroamphetamine—Nausea—Vinorelbine—lung cancer	0.000699	0.0012	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Etoposide—lung cancer	0.000697	0.00119	CcSEcCtD
Dextroamphetamine—Dyspepsia—Paclitaxel—lung cancer	0.000697	0.00119	CcSEcCtD
Dextroamphetamine—Body temperature increased—Cisplatin—lung cancer	0.000697	0.00119	CcSEcCtD
Dextroamphetamine—Asthenia—Irinotecan—lung cancer	0.000696	0.00119	CcSEcCtD
Dextroamphetamine—Fatigue—Etoposide—lung cancer	0.000696	0.00119	CcSEcCtD
Dextroamphetamine—Constipation—Etoposide—lung cancer	0.00069	0.00118	CcSEcCtD
Dextroamphetamine—Decreased appetite—Paclitaxel—lung cancer	0.000688	0.00118	CcSEcCtD
Dextroamphetamine—Dry mouth—Docetaxel—lung cancer	0.000685	0.00117	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000683	0.00117	CcSEcCtD
Dextroamphetamine—Fatigue—Paclitaxel—lung cancer	0.000682	0.00117	CcSEcCtD
Dextroamphetamine—Asthenia—Gemcitabine—lung cancer	0.000678	0.00116	CcSEcCtD
Dextroamphetamine—Constipation—Paclitaxel—lung cancer	0.000677	0.00116	CcSEcCtD
Dextroamphetamine—Photosensitivity reaction—Doxorubicin—lung cancer	0.000672	0.00115	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Docetaxel—lung cancer	0.000671	0.00115	CcSEcCtD
Dextroamphetamine—Infection—Docetaxel—lung cancer	0.000667	0.00114	CcSEcCtD
Dextroamphetamine—Weight decreased—Doxorubicin—lung cancer	0.000666	0.00114	CcSEcCtD
Dextroamphetamine—Diarrhoea—Irinotecan—lung cancer	0.000664	0.00114	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Etoposide—lung cancer	0.00066	0.00113	CcSEcCtD
Dextroamphetamine—Tachycardia—Docetaxel—lung cancer	0.000655	0.00112	CcSEcCtD
Dextroamphetamine—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000651	0.00112	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Cisplatin—lung cancer	0.000649	0.00111	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Paclitaxel—lung cancer	0.000647	0.00111	CcSEcCtD
Dextroamphetamine—Diarrhoea—Gemcitabine—lung cancer	0.000647	0.00111	CcSEcCtD
Dextroamphetamine—Erythema multiforme—Methotrexate—lung cancer	0.000644	0.0011	CcSEcCtD
Dextroamphetamine—Dizziness—Irinotecan—lung cancer	0.000642	0.0011	CcSEcCtD
Dextroamphetamine—Urticaria—Etoposide—lung cancer	0.000641	0.0011	CcSEcCtD
Dextroamphetamine—Anorexia—Docetaxel—lung cancer	0.00064	0.0011	CcSEcCtD
Dextroamphetamine—Abdominal pain—Etoposide—lung cancer	0.000638	0.00109	CcSEcCtD
Dextroamphetamine—Body temperature increased—Etoposide—lung cancer	0.000638	0.00109	CcSEcCtD
Dextroamphetamine—Urinary tract infection—Doxorubicin—lung cancer	0.000638	0.00109	CcSEcCtD
Dextroamphetamine—Asthenia—Cisplatin—lung cancer	0.000632	0.00108	CcSEcCtD
Dextroamphetamine—Sweating—Doxorubicin—lung cancer	0.000629	0.00108	CcSEcCtD
Dextroamphetamine—Urticaria—Paclitaxel—lung cancer	0.000629	0.00108	CcSEcCtD
Dextroamphetamine—Abdominal pain—Paclitaxel—lung cancer	0.000626	0.00107	CcSEcCtD
Dextroamphetamine—Body temperature increased—Paclitaxel—lung cancer	0.000626	0.00107	CcSEcCtD
Dextroamphetamine—Vomiting—Irinotecan—lung cancer	0.000617	0.00106	CcSEcCtD
Dextroamphetamine—Rash—Irinotecan—lung cancer	0.000612	0.00105	CcSEcCtD
Dextroamphetamine—Dermatitis—Irinotecan—lung cancer	0.000611	0.00105	CcSEcCtD
Dextroamphetamine—Headache—Irinotecan—lung cancer	0.000608	0.00104	CcSEcCtD
Dextroamphetamine—Insomnia—Docetaxel—lung cancer	0.000607	0.00104	CcSEcCtD
Dextroamphetamine—Diarrhoea—Cisplatin—lung cancer	0.000603	0.00103	CcSEcCtD
Dextroamphetamine—Vomiting—Gemcitabine—lung cancer	0.000601	0.00103	CcSEcCtD
Dextroamphetamine—Dyspnoea—Docetaxel—lung cancer	0.000598	0.00103	CcSEcCtD
Dextroamphetamine—Somnolence—Docetaxel—lung cancer	0.000596	0.00102	CcSEcCtD
Dextroamphetamine—Rash—Gemcitabine—lung cancer	0.000596	0.00102	CcSEcCtD
Dextroamphetamine—Dermatitis—Gemcitabine—lung cancer	0.000596	0.00102	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Etoposide—lung cancer	0.000595	0.00102	CcSEcCtD
Dextroamphetamine—Headache—Gemcitabine—lung cancer	0.000592	0.00102	CcSEcCtD
Dextroamphetamine—Dyspepsia—Docetaxel—lung cancer	0.000591	0.00101	CcSEcCtD
Dextroamphetamine—Decreased appetite—Docetaxel—lung cancer	0.000583	0.001	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Paclitaxel—lung cancer	0.000583	0.001	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Docetaxel—lung cancer	0.000579	0.000993	CcSEcCtD
Dextroamphetamine—Asthenia—Etoposide—lung cancer	0.000579	0.000993	CcSEcCtD
Dextroamphetamine—Fatigue—Docetaxel—lung cancer	0.000578	0.000991	CcSEcCtD
Dextroamphetamine—Nausea—Irinotecan—lung cancer	0.000577	0.000988	CcSEcCtD
Dextroamphetamine—Constipation—Docetaxel—lung cancer	0.000574	0.000983	CcSEcCtD
Dextroamphetamine—Asthenia—Paclitaxel—lung cancer	0.000568	0.000973	CcSEcCtD
Dextroamphetamine—Nausea—Gemcitabine—lung cancer	0.000562	0.000962	CcSEcCtD
Dextroamphetamine—Vomiting—Cisplatin—lung cancer	0.00056	0.00096	CcSEcCtD
Dextroamphetamine—Erythema multiforme—Doxorubicin—lung cancer	0.000557	0.000955	CcSEcCtD
Dextroamphetamine—Rash—Cisplatin—lung cancer	0.000556	0.000952	CcSEcCtD
Dextroamphetamine—Dermatitis—Cisplatin—lung cancer	0.000555	0.000951	CcSEcCtD
Dextroamphetamine—Diarrhoea—Etoposide—lung cancer	0.000552	0.000947	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Docetaxel—lung cancer	0.000549	0.00094	CcSEcCtD
Dextroamphetamine—Diarrhoea—Paclitaxel—lung cancer	0.000542	0.000928	CcSEcCtD
Dextroamphetamine—Dizziness—Etoposide—lung cancer	0.000534	0.000915	CcSEcCtD
Dextroamphetamine—Abdominal pain—Docetaxel—lung cancer	0.00053	0.000909	CcSEcCtD
Dextroamphetamine—Body temperature increased—Docetaxel—lung cancer	0.00053	0.000909	CcSEcCtD
Dextroamphetamine—Dizziness—Paclitaxel—lung cancer	0.000523	0.000897	CcSEcCtD
Dextroamphetamine—Nausea—Cisplatin—lung cancer	0.000523	0.000897	CcSEcCtD
Dextroamphetamine—Convulsion—Methotrexate—lung cancer	0.000513	0.00088	CcSEcCtD
Dextroamphetamine—Vomiting—Etoposide—lung cancer	0.000513	0.00088	CcSEcCtD
Dextroamphetamine—Rash—Etoposide—lung cancer	0.000509	0.000872	CcSEcCtD
Dextroamphetamine—Dermatitis—Etoposide—lung cancer	0.000509	0.000872	CcSEcCtD
Dextroamphetamine—Headache—Etoposide—lung cancer	0.000506	0.000867	CcSEcCtD
Dextroamphetamine—Chest pain—Methotrexate—lung cancer	0.000504	0.000865	CcSEcCtD
Dextroamphetamine—Tension—Doxorubicin—lung cancer	0.000503	0.000863	CcSEcCtD
Dextroamphetamine—Vomiting—Paclitaxel—lung cancer	0.000503	0.000863	CcSEcCtD
Dextroamphetamine—Rash—Paclitaxel—lung cancer	0.000499	0.000855	CcSEcCtD
Dextroamphetamine—Dermatitis—Paclitaxel—lung cancer	0.000499	0.000855	CcSEcCtD
Dextroamphetamine—Nervousness—Doxorubicin—lung cancer	0.000498	0.000854	CcSEcCtD
Dextroamphetamine—Headache—Paclitaxel—lung cancer	0.000496	0.00085	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Docetaxel—lung cancer	0.000494	0.000847	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Methotrexate—lung cancer	0.000484	0.000829	CcSEcCtD
Dextroamphetamine—Asthenia—Docetaxel—lung cancer	0.000481	0.000825	CcSEcCtD
Dextroamphetamine—Infection—Methotrexate—lung cancer	0.00048	0.000823	CcSEcCtD
Dextroamphetamine—Nausea—Etoposide—lung cancer	0.00048	0.000822	CcSEcCtD
Dextroamphetamine—Selegiline—ABCB1—lung cancer	0.000472	0.0359	CrCbGaD
Dextroamphetamine—Agitation—Doxorubicin—lung cancer	0.000471	0.000808	CcSEcCtD
Dextroamphetamine—Nausea—Paclitaxel—lung cancer	0.00047	0.000806	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Methotrexate—lung cancer	0.000467	0.000801	CcSEcCtD
Dextroamphetamine—Anorexia—Methotrexate—lung cancer	0.000461	0.00079	CcSEcCtD
Dextroamphetamine—Diarrhoea—Docetaxel—lung cancer	0.000459	0.000787	CcSEcCtD
Dextroamphetamine—Palpitations—Doxorubicin—lung cancer	0.000453	0.000777	CcSEcCtD
Dextroamphetamine—Convulsion—Doxorubicin—lung cancer	0.000445	0.000762	CcSEcCtD
Dextroamphetamine—Dizziness—Docetaxel—lung cancer	0.000444	0.00076	CcSEcCtD
Dextroamphetamine—Hypertension—Doxorubicin—lung cancer	0.000443	0.000759	CcSEcCtD
Dextroamphetamine—Nateglinide—ALB—lung cancer	0.000442	0.0337	CrCbGaD
Dextroamphetamine—Insomnia—Methotrexate—lung cancer	0.000437	0.00075	CcSEcCtD
Dextroamphetamine—Chest pain—Doxorubicin—lung cancer	0.000437	0.000749	CcSEcCtD
Dextroamphetamine—Anxiety—Doxorubicin—lung cancer	0.000435	0.000746	CcSEcCtD
Dextroamphetamine—Dyspnoea—Methotrexate—lung cancer	0.000431	0.000739	CcSEcCtD
Dextroamphetamine—Somnolence—Methotrexate—lung cancer	0.00043	0.000737	CcSEcCtD
Dextroamphetamine—Dry mouth—Doxorubicin—lung cancer	0.000427	0.000732	CcSEcCtD
Dextroamphetamine—Vomiting—Docetaxel—lung cancer	0.000427	0.000731	CcSEcCtD
Dextroamphetamine—Dyspepsia—Methotrexate—lung cancer	0.000426	0.00073	CcSEcCtD
Dextroamphetamine—Rash—Docetaxel—lung cancer	0.000423	0.000725	CcSEcCtD
Dextroamphetamine—Dermatitis—Docetaxel—lung cancer	0.000423	0.000724	CcSEcCtD
Dextroamphetamine—Decreased appetite—Methotrexate—lung cancer	0.00042	0.00072	CcSEcCtD
Dextroamphetamine—Headache—Docetaxel—lung cancer	0.00042	0.00072	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Doxorubicin—lung cancer	0.000419	0.000718	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Methotrexate—lung cancer	0.000417	0.000716	CcSEcCtD
Dextroamphetamine—Fatigue—Methotrexate—lung cancer	0.000417	0.000715	CcSEcCtD
Dextroamphetamine—Infection—Doxorubicin—lung cancer	0.000416	0.000713	CcSEcCtD
Dextroamphetamine—Tachycardia—Doxorubicin—lung cancer	0.000409	0.0007	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Doxorubicin—lung cancer	0.000405	0.000694	CcSEcCtD
Dextroamphetamine—Anorexia—Doxorubicin—lung cancer	0.000399	0.000684	CcSEcCtD
Dextroamphetamine—Nausea—Docetaxel—lung cancer	0.000399	0.000683	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Methotrexate—lung cancer	0.000395	0.000678	CcSEcCtD
Dextroamphetamine—Urticaria—Methotrexate—lung cancer	0.000384	0.000658	CcSEcCtD
Dextroamphetamine—Abdominal pain—Methotrexate—lung cancer	0.000382	0.000655	CcSEcCtD
Dextroamphetamine—Body temperature increased—Methotrexate—lung cancer	0.000382	0.000655	CcSEcCtD
Dextroamphetamine—Insomnia—Doxorubicin—lung cancer	0.000379	0.000649	CcSEcCtD
Dextroamphetamine—Dyspnoea—Doxorubicin—lung cancer	0.000373	0.00064	CcSEcCtD
Dextroamphetamine—Somnolence—Doxorubicin—lung cancer	0.000372	0.000638	CcSEcCtD
Dextroamphetamine—Dyspepsia—Doxorubicin—lung cancer	0.000369	0.000632	CcSEcCtD
Dextroamphetamine—Decreased appetite—Doxorubicin—lung cancer	0.000364	0.000624	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000362	0.00062	CcSEcCtD
Dextroamphetamine—Fatigue—Doxorubicin—lung cancer	0.000361	0.000619	CcSEcCtD
Dextroamphetamine—Constipation—Doxorubicin—lung cancer	0.000358	0.000614	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Methotrexate—lung cancer	0.000356	0.000611	CcSEcCtD
Dextroamphetamine—Asthenia—Methotrexate—lung cancer	0.000347	0.000595	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Doxorubicin—lung cancer	0.000342	0.000587	CcSEcCtD
Dextroamphetamine—Urticaria—Doxorubicin—lung cancer	0.000333	0.00057	CcSEcCtD
Dextroamphetamine—Abdominal pain—Doxorubicin—lung cancer	0.000331	0.000567	CcSEcCtD
Dextroamphetamine—Body temperature increased—Doxorubicin—lung cancer	0.000331	0.000567	CcSEcCtD
Dextroamphetamine—Diarrhoea—Methotrexate—lung cancer	0.000331	0.000567	CcSEcCtD
Dextroamphetamine—Dizziness—Methotrexate—lung cancer	0.00032	0.000548	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Doxorubicin—lung cancer	0.000309	0.000529	CcSEcCtD
Dextroamphetamine—Vomiting—Methotrexate—lung cancer	0.000307	0.000527	CcSEcCtD
Dextroamphetamine—Rash—Methotrexate—lung cancer	0.000305	0.000523	CcSEcCtD
Dextroamphetamine—Dermatitis—Methotrexate—lung cancer	0.000305	0.000522	CcSEcCtD
Dextroamphetamine—Headache—Methotrexate—lung cancer	0.000303	0.000519	CcSEcCtD
Dextroamphetamine—Asthenia—Doxorubicin—lung cancer	0.0003	0.000515	CcSEcCtD
Dextroamphetamine—Nausea—Methotrexate—lung cancer	0.000287	0.000492	CcSEcCtD
Dextroamphetamine—Diarrhoea—Doxorubicin—lung cancer	0.000287	0.000491	CcSEcCtD
Dextroamphetamine—Dizziness—Doxorubicin—lung cancer	0.000277	0.000475	CcSEcCtD
Dextroamphetamine—Vomiting—Doxorubicin—lung cancer	0.000266	0.000456	CcSEcCtD
Dextroamphetamine—Rash—Doxorubicin—lung cancer	0.000264	0.000452	CcSEcCtD
Dextroamphetamine—Dermatitis—Doxorubicin—lung cancer	0.000264	0.000452	CcSEcCtD
Dextroamphetamine—Headache—Doxorubicin—lung cancer	0.000262	0.00045	CcSEcCtD
Dextroamphetamine—Nausea—Doxorubicin—lung cancer	0.000249	0.000426	CcSEcCtD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—ALB—lung cancer	8.21e-05	0.00029	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—lung cancer	8.15e-05	0.000289	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—EP300—lung cancer	8.05e-05	0.000285	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—MTMR3—lung cancer	8.03e-05	0.000284	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—GNG11—lung cancer	7.97e-05	0.000282	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—CXCL8—lung cancer	7.83e-05	0.000277	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—SRC—lung cancer	7.83e-05	0.000277	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—lung cancer	7.83e-05	0.000277	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PGAM1—lung cancer	7.82e-05	0.000277	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—AVP—lung cancer	7.82e-05	0.000277	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—lung cancer	7.81e-05	0.000276	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PXN—lung cancer	7.73e-05	0.000273	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—AVP—lung cancer	7.65e-05	0.000271	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—VEGFA—lung cancer	7.63e-05	0.00027	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Neuronal System—HRAS—lung cancer	7.6e-05	0.000269	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—VEGFC—lung cancer	7.59e-05	0.000269	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GRP—lung cancer	7.57e-05	0.000268	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—AKR1C1—lung cancer	7.57e-05	0.000268	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—OXTR—lung cancer	7.57e-05	0.000268	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—STAT3—lung cancer	7.55e-05	0.000267	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—NRAS—lung cancer	7.53e-05	0.000267	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CYP2A7—lung cancer	7.46e-05	0.000264	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—RAF1—lung cancer	7.42e-05	0.000263	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—SDC4—lung cancer	7.3e-05	0.000259	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—lung cancer	7.24e-05	0.000256	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—MAPK3—lung cancer	7.21e-05	0.000255	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ADCY1—lung cancer	7.17e-05	0.000254	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GNG11—lung cancer	7.08e-05	0.000251	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—MYC—lung cancer	7.02e-05	0.000248	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SMARCA4—lung cancer	6.99e-05	0.000247	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PPP2R1B—lung cancer	6.99e-05	0.000247	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—CXCL8—lung cancer	6.96e-05	0.000246	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—AVP—lung cancer	6.95e-05	0.000246	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—lung cancer	6.93e-05	0.000245	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—EGFR—lung cancer	6.86e-05	0.000243	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—VEGFC—lung cancer	6.74e-05	0.000239	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HSPB1—lung cancer	6.74e-05	0.000239	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PTHLH—lung cancer	6.67e-05	0.000236	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—RRM1—lung cancer	6.65e-05	0.000235	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GSTA3—lung cancer	6.65e-05	0.000235	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—KRAS—lung cancer	6.48e-05	0.000229	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ADCY1—lung cancer	6.37e-05	0.000225	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ANXA1—lung cancer	6.27e-05	0.000222	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—B4GALT5—lung cancer	6.26e-05	0.000221	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PPP2R1B—lung cancer	6.21e-05	0.00022	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SMARCA4—lung cancer	6.21e-05	0.00022	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GSTA4—lung cancer	6.09e-05	0.000215	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—FLT1—lung cancer	6.07e-05	0.000215	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—PIK3CG—lung cancer	6.01e-05	0.000213	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HSPB1—lung cancer	5.99e-05	0.000212	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—PIK3CA—lung cancer	5.96e-05	0.000211	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NOTCH3—lung cancer	5.94e-05	0.00021	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—APP—lung cancer	5.94e-05	0.00021	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GSTA2—lung cancer	5.93e-05	0.00021	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PTHLH—lung cancer	5.92e-05	0.00021	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—FGF9—lung cancer	5.89e-05	0.000209	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—TP53—lung cancer	5.76e-05	0.000204	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—POMC—lung cancer	5.72e-05	0.000203	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GSTA1—lung cancer	5.72e-05	0.000202	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ABCC3—lung cancer	5.66e-05	0.0002	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—JUNB—lung cancer	5.63e-05	0.000199	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ANXA1—lung cancer	5.57e-05	0.000197	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—HRAS—lung cancer	5.51e-05	0.000195	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—AKR1C1—lung cancer	5.48e-05	0.000194	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PIK3CG—lung cancer	5.46e-05	0.000193	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—FLT1—lung cancer	5.39e-05	0.000191	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PIK3CG—lung cancer	5.34e-05	0.000189	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—UGT1A1—lung cancer	5.32e-05	0.000188	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—PIK3CD—lung cancer	5.29e-05	0.000187	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NOTCH3—lung cancer	5.28e-05	0.000187	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—APP—lung cancer	5.28e-05	0.000187	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—IL6—lung cancer	5.27e-05	0.000187	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—FGF9—lung cancer	5.23e-05	0.000185	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—POMC—lung cancer	5.2e-05	0.000184	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GNG11—lung cancer	5.13e-05	0.000181	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—STK11—lung cancer	5.11e-05	0.000181	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—POMC—lung cancer	5.08e-05	0.00018	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—IL6R—lung cancer	5.07e-05	0.000179	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—JUNB—lung cancer	5e-05	0.000177	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—FOXO3—lung cancer	4.93e-05	0.000174	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ALDOA—lung cancer	4.88e-05	0.000173	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—AKT1—lung cancer	4.87e-05	0.000172	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PIK3CG—lung cancer	4.85e-05	0.000172	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—MAP2K1—lung cancer	4.83e-05	0.000171	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PIK3CD—lung cancer	4.8e-05	0.00017	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—NCOA3—lung cancer	4.74e-05	0.000168	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PIK3CD—lung cancer	4.7e-05	0.000166	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—AVP—lung cancer	4.62e-05	0.000164	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—POMC—lung cancer	4.62e-05	0.000163	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ABCG2—lung cancer	4.61e-05	0.000163	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ADCY1—lung cancer	4.61e-05	0.000163	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—PIK3CB—lung cancer	4.61e-05	0.000163	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—STK11—lung cancer	4.54e-05	0.000161	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—HPGDS—lung cancer	4.52e-05	0.00016	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ENO2—lung cancer	4.52e-05	0.00016	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—IL6R—lung cancer	4.5e-05	0.000159	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PPP2R1B—lung cancer	4.49e-05	0.000159	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IGF1R—lung cancer	4.45e-05	0.000157	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—CXCL8—lung cancer	4.43e-05	0.000157	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GSTT1—lung cancer	4.39e-05	0.000155	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—FOXO3—lung cancer	4.38e-05	0.000155	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HES1—lung cancer	4.37e-05	0.000155	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GCLC—lung cancer	4.34e-05	0.000153	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CYP2A6—lung cancer	4.34e-05	0.000153	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—MAP2K1—lung cancer	4.29e-05	0.000152	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—RAF1—lung cancer	4.29e-05	0.000152	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PIK3CD—lung cancer	4.26e-05	0.000151	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—IL2—lung cancer	4.23e-05	0.00015	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PIK3CB—lung cancer	4.18e-05	0.000148	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ENO1—lung cancer	4.11e-05	0.000145	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—AVP—lung cancer	4.1e-05	0.000145	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PIK3CB—lung cancer	4.09e-05	0.000145	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CXCL8—lung cancer	4.02e-05	0.000142	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ERBB3—lung cancer	3.99e-05	0.000141	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IGF1R—lung cancer	3.95e-05	0.00014	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—CXCL8—lung cancer	3.93e-05	0.000139	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HES1—lung cancer	3.88e-05	0.000137	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—IL2—lung cancer	3.84e-05	0.000136	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TERT—lung cancer	3.83e-05	0.000135	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—RAF1—lung cancer	3.81e-05	0.000135	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—IL2—lung cancer	3.76e-05	0.000133	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—FGFR1—lung cancer	3.72e-05	0.000132	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PIK3CB—lung cancer	3.72e-05	0.000132	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CYP2E1—lung cancer	3.69e-05	0.00013	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HIF1A—lung cancer	3.66e-05	0.00013	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—NQO1—lung cancer	3.65e-05	0.000129	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CXCL8—lung cancer	3.57e-05	0.000126	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ERBB3—lung cancer	3.55e-05	0.000126	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—APOA1—lung cancer	3.53e-05	0.000125	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—KDR—lung cancer	3.5e-05	0.000124	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—IL2—lung cancer	3.41e-05	0.000121	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TERT—lung cancer	3.4e-05	0.00012	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—FGFR1—lung cancer	3.3e-05	0.000117	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—STK11—lung cancer	3.29e-05	0.000116	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HIF1A—lung cancer	3.25e-05	0.000115	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PIK3CG—lung cancer	3.23e-05	0.000114	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—APC—lung cancer	3.23e-05	0.000114	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—KIT—lung cancer	3.23e-05	0.000114	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—NRAS—lung cancer	3.23e-05	0.000114	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—EGF—lung cancer	3.19e-05	0.000113	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—APOA1—lung cancer	3.14e-05	0.000111	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—KDR—lung cancer	3.11e-05	0.00011	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—MAPK3—lung cancer	3.09e-05	0.000109	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—POMC—lung cancer	3.07e-05	0.000109	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GSTP1—lung cancer	3.04e-05	0.000108	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—BRAF—lung cancer	3.03e-05	0.000107	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IL6R—lung cancer	3e-05	0.000106	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CREBBP—lung cancer	2.99e-05	0.000106	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CAT—lung cancer	2.96e-05	0.000105	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—EGFR—lung cancer	2.94e-05	0.000104	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ABCB1—lung cancer	2.88e-05	0.000102	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—APC—lung cancer	2.87e-05	0.000101	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—KIT—lung cancer	2.87e-05	0.000101	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PIK3CG—lung cancer	2.87e-05	0.000101	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—NRAS—lung cancer	2.87e-05	0.000101	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MAP2K1—lung cancer	2.85e-05	0.000101	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PIK3CD—lung cancer	2.84e-05	0.0001	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—EGF—lung cancer	2.83e-05	0.0001	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—TYMS—lung cancer	2.83e-05	0.0001	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—PIK3CA—lung cancer	2.81e-05	9.94e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GSTM1—lung cancer	2.79e-05	9.89e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—KRAS—lung cancer	2.78e-05	9.82e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—MAPK3—lung cancer	2.74e-05	9.71e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—POMC—lung cancer	2.73e-05	9.65e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—BRAF—lung cancer	2.69e-05	9.53e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IL6R—lung cancer	2.66e-05	9.41e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CREBBP—lung cancer	2.66e-05	9.4e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CYP1A1—lung cancer	2.65e-05	9.37e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ERCC2—lung cancer	2.63e-05	9.3e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—EGFR—lung cancer	2.61e-05	9.24e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PIK3CA—lung cancer	2.55e-05	9.03e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MDM2—lung cancer	2.54e-05	8.99e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MAP2K1—lung cancer	2.54e-05	8.97e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—RAF1—lung cancer	2.53e-05	8.96e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PIK3CD—lung cancer	2.52e-05	8.91e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ERBB2—lung cancer	2.5e-05	8.86e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PIK3CA—lung cancer	2.49e-05	8.83e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PIK3CB—lung cancer	2.47e-05	8.75e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MTOR—lung cancer	2.47e-05	8.75e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—KRAS—lung cancer	2.47e-05	8.73e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CXCL8—lung cancer	2.38e-05	8.41e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—HRAS—lung cancer	2.36e-05	8.35e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—AKT1—lung cancer	2.29e-05	8.12e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CASP3—lung cancer	2.27e-05	8.05e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—APOA1—lung cancer	2.27e-05	8.04e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IL2—lung cancer	2.27e-05	8.03e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PIK3CA—lung cancer	2.27e-05	8.02e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—IL6—lung cancer	2.26e-05	7.99e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MDM2—lung cancer	2.26e-05	7.99e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—RAF1—lung cancer	2.25e-05	7.96e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ERBB2—lung cancer	2.22e-05	7.87e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CCND1—lung cancer	2.21e-05	7.83e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—JUN—lung cancer	2.21e-05	7.81e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MTOR—lung cancer	2.2e-05	7.77e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PIK3CB—lung cancer	2.2e-05	7.77e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MMP9—lung cancer	2.15e-05	7.6e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CDKN1A—lung cancer	2.14e-05	7.58e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PTEN—lung cancer	2.14e-05	7.56e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CXCL8—lung cancer	2.11e-05	7.47e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—HRAS—lung cancer	2.1e-05	7.42e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—AKT1—lung cancer	2.08e-05	7.37e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PIK3CG—lung cancer	2.07e-05	7.34e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—AKT1—lung cancer	2.04e-05	7.21e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—EP300—lung cancer	2.04e-05	7.21e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CASP3—lung cancer	2.02e-05	7.15e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IL2—lung cancer	2.02e-05	7.14e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—IL6—lung cancer	2.01e-05	7.1e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SRC—lung cancer	1.98e-05	7.01e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—POMC—lung cancer	1.97e-05	6.99e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CCND1—lung cancer	1.97e-05	6.96e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—JUN—lung cancer	1.96e-05	6.94e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—VEGFA—lung cancer	1.93e-05	6.83e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CREBBP—lung cancer	1.92e-05	6.81e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—STAT3—lung cancer	1.91e-05	6.76e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MMP9—lung cancer	1.91e-05	6.75e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NRAS—lung cancer	1.91e-05	6.74e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CDKN1A—lung cancer	1.9e-05	6.73e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PTEN—lung cancer	1.9e-05	6.71e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—AKT1—lung cancer	1.85e-05	6.55e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MAPK3—lung cancer	1.82e-05	6.46e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PIK3CD—lung cancer	1.82e-05	6.45e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—EP300—lung cancer	1.81e-05	6.4e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ALB—lung cancer	1.8e-05	6.37e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MYC—lung cancer	1.77e-05	6.28e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SRC—lung cancer	1.76e-05	6.23e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—EGFR—lung cancer	1.74e-05	6.14e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—VEGFA—lung cancer	1.71e-05	6.06e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—STAT3—lung cancer	1.7e-05	6e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NRAS—lung cancer	1.69e-05	5.99e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—KRAS—lung cancer	1.64e-05	5.8e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MAPK3—lung cancer	1.62e-05	5.74e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PIK3CB—lung cancer	1.59e-05	5.63e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MYC—lung cancer	1.58e-05	5.58e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PTGS2—lung cancer	1.58e-05	5.57e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—EGFR—lung cancer	1.54e-05	5.46e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PIK3CA—lung cancer	1.51e-05	5.33e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TP53—lung cancer	1.46e-05	5.16e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—KRAS—lung cancer	1.46e-05	5.16e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HRAS—lung cancer	1.39e-05	4.93e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PTEN—lung cancer	1.37e-05	4.86e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PIK3CA—lung cancer	1.34e-05	4.74e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IL6—lung cancer	1.33e-05	4.72e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—EP300—lung cancer	1.31e-05	4.64e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TP53—lung cancer	1.29e-05	4.58e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HRAS—lung cancer	1.24e-05	4.38e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—AKT1—lung cancer	1.23e-05	4.36e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IL6—lung cancer	1.19e-05	4.19e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—AKT1—lung cancer	1.09e-05	3.87e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PIK3CA—lung cancer	9.69e-06	3.43e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—AKT1—lung cancer	7.92e-06	2.8e-05	CbGpPWpGaD
